We are looking forward to the start of this trial. Hopefully, the outcome will provide important clues as to how juries may rule in similar DePuy ASR lawsuits.
New York, New York (PRWEB) May 08, 2013
The first bellwether trial for thousands of DePuy ASR hip lawsuits pending before the U.S. District Court, Northern District of Ohio, has been rescheduled, Bernstein Liebhard LLP reports. Originally slated to open on June 3rd, the trial will now begin on September 9th, as per an order issued by U.S. District Judge David A. Katz on May 7th. The next status conference in the federal DePuy ASR litigation will be held on May 14th, according to the Order.
“We are looking forward to the start of this trial. Hopefully, the outcome will provide important clues as to how juries may rule in similar DePuy ASR lawsuits,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, including hundreds of clients in DePuy ASR lawsuits. The Firm continues to offer free legal evaluations to anyone who suffered serious complications associated with the DePuy ASR recall.
DePuy ASR Hip Lawsuits
The DePuy ASR recall was announced in August 2010, after the metal-on-metal hip implants were found to be failing in 12-13% of recipients within just five years of implantation. Court records indicate that there are more than 10,000 DePuy ASR hip lawsuits currently pending in courts throughout the U.S., most of which have been filed in the litigation underway in Ohio. In March, a Los Angeles Superior Court jury awarded more than $8 million to a plaintiff in the nation’s first trial involving the ASR recall (Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County). However, a jury in Chicago found for Johnson & Johnson in a second trial just one month later. (Strum v. DePuy, 2011-L-9352, Circuit Court of Cook County). According to an April 16th report from The New York Times, documents submitted as evidence in both of those trials indicated that Johnson & Johnson and its DePuy Orthopaedics unit knew that the ASR was flawed years before the recall was announced, but did not disclose this information to the public or the medical community.*
Following the announcement of the DePuy ASR recall, the U.S. Food & Drug Administration (FDA) launched a safety review of metal-on-metal hip implants. In January, the agency proposed a new regulation that would make such devices ineligible for the agency’s 510(k) clearance process, which allowed all-metal hips like the ASR hip to gain FDA approval without first undergoing human clinical trials. The FDA also advised doctors to consider metal ion testing in metal hip patients who are experiencing symptoms that might indicate their implant is failing.**
Bernstein Liebhard LLP is actively filing claims in the DePuy ASR litigation underway in Ohio. Individuals who suffered metallosis, premature device failure or other complications allegedly related to the DePuy ASR hip recall may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. A wealth of information regarding DePuy ASR hip lawsuits is available on Bernstein Liebhard LLP’s website. For a free case review, please contact one of our attorneys by calling 877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP